Multidisciplinary care for people with Parkinson’s disease: the new kids on the block!

References

• Chaudhuri KR, Healy DG, Schapira AH, et al. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006 Mar;5(3):235–245.
   PubMed Web of Science ®Google Scholar
• Poewe W. Non-motor symptoms in Parkinson’s disease. Eur J Neurol. 2008 Apr;15(Suppl 1):14–20.
   PubMed Web of Science ®Google Scholar
• Zis P, Erro R, Walton CC, et al. The range and nature of non-motor symptoms in drug-naive Parkinson’s disease patients: a state-of-the-art systematic review. NPJ Parkinsons Dis. 2015 Jul 9;1:15013.
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Sauerbier A, Rojo JM, et al. The burden of non-motor symptoms in Parkinson’s disease using a self-completed non-motor questionnaire: a simple grading system. Parkinsonism Relat Disord. 2015 Mar;21(3):287–291.
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009 May;8(5):464–474.
   PubMed Web of Science ®Google Scholar
• Jenner P. Treatment of the later stages of Parkinson’s disease - pharmacological approaches now and in the future. Transl Neurodegener. 2015 Feb 12;4:3.
   PubMed Web of Science ®Google Scholar
• van der Marck MA, Kalf JG, Sturkenboom IH, et al. Multidisciplinary care for patients with Parkinson’s disease. Parkinsonism Relat Disord. 2009 Dec;15(Suppl 3):S219–S223.
   PubMedGoogle Scholar
• van der Eijk M, Nijhuis FA, Faber MJ, et al. Moving from physician-centered care towards patient-centered care for Parkinson’s disease patients. Parkinsonism Relat Disord. 2013 Nov;19(11):923–927.
   PubMed Web of Science ®Google Scholar
• Boon H, Verhoef M, O’Hara D, et al. From parallel practice to integrative health care: a conceptual framework. BMC Health Serv Res. 2004 Jul 1;4(1):15.
   PubMed Web of Science ®Google Scholar
• Jessup RL. Interdisciplinary versus multidisciplinary care teams: do we understand the difference? Aust Health Rev. 2007 Aug;31(3):330–331.
   PubMed Web of Science ®Google Scholar
• Radder DLM, Sturkenboom IH, van Nimwegen M, et al. Physical therapy and occupational therapy in Parkinson’s disease. Int J Neurosci. 2017 Oct;127(10):930–943.
   PubMed Web of Science ®Google Scholar
• Karazivan P, Dumez V, Flora L, et al. The patient-as-partner approach in health care: a conceptual framework for a necessary transition. Acad Med. 2015 Apr;90(4):437–441.
   PubMed Web of Science ®Google Scholar
• Lindberg C, Sivberg B, Willman A, et al. A trajectory towards partnership in care–patient experiences of autonomy in intensive care: A qualitative study. Intensive Crit Care Nurs. 2015 Oct;31(5):294–302.
   PubMed Web of Science ®Google Scholar
• Richards T. Listen to patients first. BMJ. 2014 Sep 23;349:g5765.
   PubMedGoogle Scholar
• van der Eijk M, Faber MJ, Post B, et al. Capturing patients’ experiences to change Parkinson’s disease care delivery: a multicenter study. J Neurol. 2015 Nov;262(11):2528–2538.
   PubMed Web of Science ®Google Scholar
• Lipsmeier F, Taylor KI, Kilchenmann T, et al. Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson’s disease clinical trial. Mov Disord. 2018 Aug;33(8):1287–1297.
   PubMed Web of Science ®Google Scholar
• Riggare S, Hägglund M. Precision medicine in Parkinson’s disease - exploring patient-initiated self-tracking. J Parkinsons Dis. 2018;8(3):441–446.
   PubMedGoogle Scholar
• Nijhuis FA, van Heek J, Bloem BR, et al. Choosing an Advanced Therapy in Parkinson’s Disease; is it an evidence-based decision in current practice? J Parkinsons Dis. 2016 Jul 25;6(3):533–543.
   PubMedGoogle Scholar
• van Peperstraten A, Nelen W, Grol R, et al. The effect of a multifaceted empowerment strategy on decision making about the number of embryos transferred in in vitro fertilisation: randomised controlled trial. BMJ. 2010 Sep 30;341:c2501.
   PubMedGoogle Scholar
• Vlaanderen FP, Rompen L, Munneke M, et al. The voice of the Parkinson customer. J Parkinsons Dis. 2018 Oct 23. Vol. Pre-press, pp. 1-5.
   PubMedGoogle Scholar
• Kremer JA, Van Der Eijk M, Aarts JW, et al. The individual formerly known as patient, TIFKAP. Minerva Med. 2011 Dec;102(6):505.
   PubMed Web of Science ®Google Scholar
• Hellqvist C, Dizdar N, Hagell P, et al. Improving self-management for persons with Parkinson’s disease through education focusing on management of daily life: patients’ and relatives’ experience of the Swedish National Parkinson School. J Clin Nurs. 2018 Oct;27(19–20):3719–3728.
   PubMed Web of Science ®Google Scholar
• Berger S, Chen T, Eldridge J, et al. The self-management balancing act of spousal care partners in the case of Parkinson’s disease. Disabil Rehabil. 2017 Dec 12:1–9.
   PubMed Web of Science ®Google Scholar
• Espay AJ, LeWitt PA, Hauser RA, et al. Neurogenic orthostatic hypotension and supine hypertension in Parkinson’s disease and related synucleinopathies: prioritisation of treatment targets. Lancet Neurol. 2016 Aug;15(9):954–966.
   PubMed Web of Science ®Google Scholar
• Noack C, Schroeder C, Heusser K, et al. Cardiovascular effects of levodopa in Parkinson’s disease. Parkinsonism Relat Disord. 2014 Aug;20(8):815–818.
   PubMed Web of Science ®Google Scholar
• Velseboer DC, de Haan RJ, Wieling W, et al. Prevalence of orthostatic hypotension in Parkinson’s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2011 Dec;17(10):724–729.
   PubMed Web of Science ®Google Scholar
• Antonini A, Barone P, Marconi R, et al. The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of life. J Neurol. 2012 Dec;259(12):2621–2631.
   PubMed Web of Science ®Google Scholar
• Ten Harmsen BL, van Rumund A, Aerts MB, et al. Clinical correlates of cerebral white matter abnormalities in patients with Parkinson’s disease. Parkinsonism Relat Disord. 2018 Apr;49:28–33.
   PubMed Web of Science ®Google Scholar
• Thijs RD, Bloem BR, van Dijk JG. Falls, faints, fits and funny turns. J Neurol. 2009 Feb;256(2):155–167.
   PubMed Web of Science ®Google Scholar
• Gibbons CH, Schmidt P, Biaggioni I, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017 Aug;264(8):1567–1582.
   PubMed Web of Science ®Google Scholar
• Hommel A, Faber MJ, Weerkamp NJ, et al. Prevalence and prescribed treatments of orthostatic hypotension in institutionalized patients with Parkinson’s disease. J Parkinsons Dis. 2016 Oct19;6(4):805–810.
   PubMedGoogle Scholar
• Ten Harkel AD, Van Lieshout JJ, Wieling W. Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone. J Intern Med. 1992 Aug;232(2):139–145.
   PubMed Web of Science ®Google Scholar
• Shibao C, Lipsitz LA, Biaggioni I. ASH position paper: evaluation and treatment of orthostatic hypotension. J Clin Hypertens (Greenwich). 2013 Mar;15(3):147–153.
   PubMed Web of Science ®Google Scholar
• Parkinson J. An essay on the shaking palsy. London: Whittingham and Rowland; 1817.
   Google Scholar
• Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Parkinsonism Relat Disord. 2011 Jan;17(1):10–15.
   PubMed Web of Science ®Google Scholar
• Pedrosa Carrasco AJ, Timmermann L, Pedrosa DJ. Management of constipation in patients with Parkinson’s disease. NPJ Parkinsons Dis. 2018 Mar 16;4:6.
   PubMed Web of Science ®Google Scholar
• Suttrup I, Suttrup J, Suntrup-Krueger S, et al. Esophageal dysfunction in different stages of Parkinson’s disease. Neurogastroenterol Motil. 2017 Jan; 29(1):1-7.
   PubMed Web of Science ®Google Scholar
• Simons JA. Swallowing dysfunctions in Parkinson’s disease. Int Rev Neurobiol. 2017;134:1207–1238.
   PubMed Web of Science ®Google Scholar
• Ali GN, Wallace KL, Schwartz R, et al. Mechanisms of oral-pharyngeal dysphagia in patients with Parkinson’s disease. Gastroenterology. 1996 Feb;110(2):383–392.
   PubMed Web of Science ®Google Scholar
• Su A, Gandhy R, Barlow C, et al. Clinical and manometric characteristics of patients with Parkinson’s disease and esophageal symptoms. Dis Esophagus. 2017 Apr1;30(4):1–6.
   Web of Science ®Google Scholar
• Bestetti A, Capozza A, Lacerenza M, et al. Delayed gastric emptying in advanced Parkinson disease: correlation with therapeutic doses. Clin Nucl Med. 2017 Feb;42(2):83–87.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Violante M, Zerón-Martínez R, Cervantes-Arriaga A, et al. Who can diagnose Parkinson’s disease first? Role of pre-motor symptoms. Arch Med Res. 2017 Apr;48(3):221–227.
   PubMed Web of Science ®Google Scholar
• Larsson V, Torisson G, Bülow M, et al. Effects of carbonated liquid on swallowing dysfunction in dementia with Lewy bodies and Parkinson’s disease dementia. Clin Interv Aging. 2017;Aug 8;12:1215–1222.
   PubMed Web of Science ®Google Scholar
• Restivo DA, Palmeri A, Marchese-Ragona R. Botulinum toxin for cricopharyngeal dysfunction in Parkinson’s disease. N Engl J Med. 2002 Apr 11;346(15):1174–1175.
   PubMed Web of Science ®Google Scholar
• Born LJ, Harned RH, Rikkers LF, et al. Cricopharyngeal dysfunction in Parkinson’s disease: role in dysphagia and response to myotomy. Mov Disord. 1996 Jan;11(1):53–58.
   PubMed Web of Science ®Google Scholar
• Triadafilopoulos G, Gandhy R, Barlow C. Pilot cohort study of endoscopic botulinum neurotoxin injection in Parkinson’s disease. Parkinsonism Relat Disord. 2017 Nov;44:33–37.
   PubMed Web of Science ®Google Scholar
• Renoux C, Dell’Aniello S, Khairy P, et al. Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson’s disease. Br J Clin Pharmacol. 2016 Aug;82(2):461–472.
   PubMed Web of Science ®Google Scholar
• Barboza JL, Okun MS, Moshiree B. The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson’s disease. Expert Opin Pharmacother. 2015;16(16):2449–2464.
   PubMed Web of Science ®Google Scholar
• Zangaglia R, Martignoni E, Glorioso M, et al. Macrogol for the treatment of constipation in Parkinson’s disease. A randomized placebo-controlled study. Mov Disord. 2007 Jul15;22(9):1239–1244.
   PubMed Web of Science ®Google Scholar
• Stocchi F, Torti M. Constipation in Parkinson’s disease. Int Rev Neurobiol. 2017;134:811–826.
   PubMed Web of Science ®Google Scholar
• Auyeung M, Tsoi TH, Mok V, et al. Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson’s disease patients. J Neurol Neurosurg Psychiatry. 2012 Jun;83(6):607–611.
   PubMed Web of Science ®Google Scholar
• Baille G, De Jesus AM, Perez T, et al. Ventilatory dysfunction in Parkinson’s disease. J Parkinsons Dis. 2016 Jun 16;6(3):463–471.
   PubMedGoogle Scholar
• Michaelee H, Yazdchi M, Ansarin M, et al. Pulmonary function tests abnormalities in Parkinson disease. Internet J Pulm Med. 2006;(8):2.
   Google Scholar
• Guedes LU, Rodrigues JM, Fernandes AA, et al. Respiratory changes in Parkinson disease may be unrelated to dopaminergic dysfunction. Arq Neruopsiquiatr. 2012;70(11):847–851.
   PubMed Web of Science ®Google Scholar
• Roussos CS, Fixley M, Gross D, et al. Fatigue of inspiratory muscles and their synergic behavior. J Appl Physiol Respir Environ Exerc Physiol. 1979 May;46(5):897–904.
   PubMed Web of Science ®Google Scholar
• Macklem PT, Roussos C, Gross D, et al. Diaphragmatic fatigue [proceedings]. Am Rev Respir Dis. 1979 Feb;119(2 Pt 2):93.
   PubMedGoogle Scholar
• Gross D, Grassino A, Ross WRD, et al. Electromyogram pattern of diaphragmatic fatigue. J Appl Physiol Respir Environ Exerc Physiol. 1979 Jan;46(1):1–7.
   PubMed Web of Science ®Google Scholar
• Gross D, Ladd H, Riley EJ, et al. The effect of training on strength and endurance of the diaphragm in quadriplegia. Am J Med. 1980 Jan;68(1):27–35.
   PubMed Web of Science ®Google Scholar
• Inzelberg R, Peleg N, Nisipeanu P, et al. Inspiratory muscle training and perception of dyspnea in Parkinson disease. Can J Neurol Sci. 2005 May;32(2):213–217.
   PubMed Web of Science ®Google Scholar
• Gross D, Meiner Z. The effect of ventilatory muscle training on respiratory function and capacity in ambulatory and bed ridden patients with neuromuscular disease. Monaldi Arch Chest Dis. 1993 Aug;48(4):322–326.
   PubMedGoogle Scholar
• Gross D, Drory V. Respiratory rehabilitation and noninvasive ventilation in patients with ALS. First Int Conf Isr Respir Rehabil. 2000 Mar 14–16;55(1):vi.
   Google Scholar
• Ventilatory muscle training in neuromuscular conditions. In: Bach J, editor. Physical medicine & rehabilitation, state of the art reviews. 1995. p. 347–352.
   Google Scholar
• Drory V, Gross D. Early noninvasive ventilation and respiratory rehabilitation program reduces morbidity and hospitalization in ALS patients compared with tracheostomized ALS patients. European Respiratory Society Meeting; 1999 Oct; Madrid.
   Google Scholar
• Amick MM, Grace J, Ott BR. Visual and cognitive predictors of driving safety in Parkinson’s disease patients. Arch Clin Neuropsychol. 2007 Nov;22(8):957–967.
   PubMed Web of Science ®Google Scholar
• Biousse V, Skibell BC, Watts RL, et al. Ophthalmologic features of Parkinson’s disease. Neurology. 2004 Jan27;62(2):177–180.
   PubMed Web of Science ®Google Scholar
• Irving EL, Chriqui E, Law C, et al. Prevalence of convergence insufficiency in Parkinson’s disease. Mov Disord Clin Pract. 2016;4(3):424–429.
   PubMed Web of Science ®Google Scholar
• Fenelon G, Mahieux F, Huon R, et al. Hallucinations in Parkinson’s disease: prevalence, phenomenology and risk factors. Brain. 2000 Apr;123(Pt 4):733–745.
   PubMed Web of Science ®Google Scholar
• Pucker AD, Ng SM, Nichols JJ. Over the counter (OTC) artificial tears drops for dry eye syndrome. Cochrane Database Syst Rev. 2016 Feb 23;2:CD009729.
   PubMed Web of Science ®Google Scholar
• Agostino R, Bologna M, Dinapoli L, et al. Voluntary, spontaneous, and reflex blinking in Parkinson’s disease. Mov Disord. 2008 Apr15;23(5):669–675.
   PubMed Web of Science ®Google Scholar
• Weil RS, Schrag AE, Warren JD, et al. Visual dysfunction in Parkinson’s disease. Brain. 2016 Nov 1;139(11):2827–2843.
   PubMed Web of Science ®Google Scholar
• Coyne KS, Wein AJ, Tubaro A, et al. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: epiLUTS. BJU Int. 2009 Apr;103(Suppl 3):4–11.
   PubMed Web of Science ®Google Scholar
• Hattori T, Yasuda K, Kita K, et al. Voiding dysfunction in Parkinson’s disease. Jpn J Psychiatry Neurol. 1992 Mar;46(1):181–186.
   PubMedGoogle Scholar
• Sakakibara R, Shinotoh H, Uchiyama T, et al. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson’s disease. Auton Neurosci. 2001 Sep17;92(1–2):76–85.
   PubMed Web of Science ®Google Scholar
• Winge K, Skau AM, Stimpel H, et al. Prevalence of bladder dysfunction in Parkinsons disease. Neurourol Urodyn. 2006;25(2):116–122.
   PubMed Web of Science ®Google Scholar
• Georgopoulos P, Vaios Mytilekas K, Apostolidis P. Chapter Degenerative diseases; Multiple Sclerosis, Parkinson’s disease. In: Dmochowski R, Heesakkers J, editors. Neuro-Urology. Springer International Publishing AG, New York City, New York, United States of America; 2018; pp. 55-79. isbn 978-3-319-90995–0.
   Google Scholar
• Bhattacharyya KB, Rosa-Grilo M. Sexual dysfunctions in Parkinson’s disease: an underrated problem in a much discussed disorder. Int Rev Neurobiol. 2017;134:859–876.
   PubMed Web of Science ®Google Scholar
• Bronner G, Korczyn AD. The role of sex therapy in the management of patients with Parkinson’s disease. Mov Disord Clin Pract. 2017 Nov 16;5(1):6–13.
   PubMed Web of Science ®Google Scholar
• Koopmans RT, Lavrijsen JC, Hoek JF, et al. Dutch elderly care physician: a new generation of nursing home physician specialists. J Am Geriatr Soc. 2010 Sep;58(9):1807–1809.
   PubMed Web of Science ®Google Scholar
• de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006 Jun;5(6):525–535.
   PubMed Web of Science ®Google Scholar
• Ruikes FG, Zuidema SU, Akkermans RP, et al. Multicomponent program to reduce functional decline in frail elderly people: a cluster controlled trial. J Am Board Fam Med. 2016 Mar–Apr;29(2):209–217.
   PubMed Web of Science ®Google Scholar
• Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. Lancet. 2013 Mar2;381(9868):752–762.
   PubMed Web of Science ®Google Scholar
• Coelho M, Ferreira JJ. Late-stage Parkinson disease. Nat Rev Neurol. 2012 Aug 8;8:435–442.
   PubMed Web of Science ®Google Scholar
• Aarsland D, Larsen JP, Tandberg E, et al. Predictors of nursing home placement in Parkinson’s disease: a population-based, prospective study. J Am Geriatr Soc. 2000 Aug;48(8):938–942.
   PubMed Web of Science ®Google Scholar
• Hely MA, Morris JG, Reid WG, et al. Sydney multicenter study of Parkinson’s disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord. 2005 Feb;20(2):190–199.
   PubMed Web of Science ®Google Scholar
• Wressle E, Engstrand C, Granérus AK. Living with Parkinson’s disease: elderly patients’ and relatives’ perspective on daily living. Aust Occup Ther J. 2007 Jun 1;54(2):131–139.
   Web of Science ®Google Scholar
• Lökk J. Reduced life-space of non-professional caregivers to Parkinson’s disease patients with increased disease duration. Clin Neurol Neurosurg. 2009 Sep;111(7):583–587.
   PubMed Web of Science ®Google Scholar
• Palmer K, Onder G. Comprehensive geriatric assessment: benefits and limitations. Eur J Intern Med. 2018 Aug;54:e8–e9.
   PubMed Web of Science ®Google Scholar
• Ancelin ML, Artero S, Portet F, et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ. 2006 Feb25;332(7539):455–459.
   PubMed Web of Science ®Google Scholar
• Ehrt U, Broich K, Larsen JP, et al. Use of drugs with anticholinergic effect and impact on cognition in Parkinson’s disease: a cohort study. J Neurol Neurosurg Psychiatry. 2010 Feb;81(2):160–165.
   PubMed Web of Science ®Google Scholar
• Hertogh C, Deerenberg-Kessler W, Ribbe MW. The problem-oriented multidisciplinary approach in Dutch nursing home care. Clin Rehabil. 1996;10:135–142.
   Google Scholar
• Koopmans RTCM, Pellegrom M, van der Geer ER. The Dutch move beyond the concept of nursing home physician specialists. J Am Med Dir Assoc. 2017 Sep 1;18(9):746–749.
   PubMed Web of Science ®Google Scholar
• van der Steen JT, Kruse RL, Ooms ME, et al. Treatment of nursing home residents with dementia and lower respiratory tract infection in the United States and The Netherlands: an ocean apart. J Am Geriatr Soc. 2004 May;52(5):691–699.
   PubMed Web of Science ®Google Scholar
• Coelho M, Marti MJ, Tolosa E, et al. Late-stage Parkinson’s disease: the Barcelona and Lisbon cohort. J Neurol. 2010 Sep;257(9):1524–1532.
   PubMed Web of Science ®Google Scholar
• van Rumund A, Weerkamp N, Tissingh G, et al. Perspectives on Parkinson disease care in Dutch nursing homes. J Am Med Dir Assoc. 2014 Oct;15(10):732–737.
   PubMed Web of Science ®Google Scholar
• Richfield EW, Jones EJ, Alty JE. Palliative care for Parkinson’s disease: a summary of the evidence and future directions. Palliat Med. 2013 Oct;27(9):805–810.
   PubMed Web of Science ®Google Scholar
• Lee MA, Prentice WM, Hildreth AJ, et al. Measuring symptom load in Idiopathic Parkinson’s disease. Parkinsonism Relat Disord. 2007 Jul;13(5):284–289.
   PubMed Web of Science ®Google Scholar
• Higginson IJ, Gao W, Saleem TZ, et al. Symptoms and quality of life in late stage Parkinson syndromes: a longitudinal community study of predictive factors. PLoS One. 2012;7(11):e46327.
   PubMed Web of Science ®Google Scholar
• Buter TC, van Den Hout A, Matthews FE, et al. Dementia and survival in Parkinson disease: a 12-year population study. Neurology. 2008 Mar25;70(13):1017–1022.
   PubMed Web of Science ®Google Scholar
• Saleem TZ, Higginson IJ, Chaudhuri KR, et al. Symptom prevalence, severity and palliative care needs assessment using the Palliative Outcome Scale: a cross-sectional study of patients with Parkinson’s disease and related neurological conditions. Palliat Med. 2013 Sep;27(8):722–731.
   PubMed Web of Science ®Google Scholar
• Miyasaki JM, Kluger B. Palliative care for Parkinson’s disease: has the time come? Curr Neurol Neurosci Rep. 2015 May;15(5):26.
   PubMed Web of Science ®Google Scholar
• Hasson F, Kernohan WG, McLaughlin M, et al. An exploration into the palliative and end-of-life experiences of carers of people with Parkinson’s disease. Palliat Med. 2010 Oct;24(7):731–736.
   PubMed Web of Science ®Google Scholar
• McLaughlin D, Hasson F, Kernohan WG, et al. Living and coping with Parkinson’s disease: perceptions of informal carers. Palliat Med. 2011 Mar;25(2):177–182.
   PubMed Web of Science ®Google Scholar
• Goy ER, Carter JH, Ganzini L. Needs and experiences of caregivers for family members dying with Parkinson disease. J Palliat Care. 2008 Summer;24(2):69–75.
   PubMed Web of Science ®Google Scholar
• Giles S, Miyasaki J. Palliative stage Parkinson’s disease: patient and family experiences of health-care services. Palliat Med. 2009 Mar;23(2):120–125.
   PubMed Web of Science ®Google Scholar
• Schrag A, Hovris A, Morley D, et al. Caregiver-burden in parkinson’s disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat Disord. 2006 Jan;12(1):35–41.
   PubMed Web of Science ®Google Scholar
• Varanese S, Birnbaum Z, Rossi R, et al. Treatment of advanced Parkinson’s disease. Parkinsons Dis. 2011 Feb 7;2010:480260.
   PubMed Web of Science ®Google Scholar
• Lapane KL, Fernandez HH, Friedman JH. Prevalence, clinical characteristics, and pharmacologic treatment of Parkinson’s disease in residents in long-term care facilities. SAGE study group. Pharmacotherapy. 1999 Nov;19(11):1321–1327.
   PubMed Web of Science ®Google Scholar
• Waldron M, Kernohan WG, Hasson F, et al. What do social workers think about the palliative care needs of people with Parkinson’s disease? Br J Soc Work. 2013 Nov;43(1):81–98.
   Web of Science ®Google Scholar
• Waldron M, Kernohan WG, Hasson F, et al. Allied health professional’s views on palliative care for people with advanced Parkinson’s disease. Int J Ther Rehabil. 2011 Jan;18(1):48–58.
   Google Scholar
• Fox S, Cashell A, Kernohan WG, et al. Interviews with Irish healthcare workers from different disciplines about palliative care for people with Parkinson’s disease: a definite role but uncertainty around terminology and timing. BMC Palliat Care. 2016 Feb 9;15:15.
   PubMed Web of Science ®Google Scholar
• Fox S, Gannon E, Cashell A, et al. Survey of health care workers suggests unmet palliative care needs in Parkinson’s disease. Mov Disord Clin Pract. 2015 Apr;2(2):142–148.
   PubMed Web of Science ®Google Scholar
• Boersma I, Miyasaki J, Kutner J, et al. Palliative care and neurology: time for a paradigm shift. Neurology. 2014 Aug5;83(6):561–567.
   PubMed Web of Science ®Google Scholar
• Fukayo S, Nonaka K, Shimizu T, et al. Oral health of patients with Parkinson’s disease: factors related to their better dental status. Tohoku J Exp Med. 2003 Nov;201(3):171–179.
   PubMed Web of Science ®Google Scholar
• Zlotnik Y, Balash Y, Korczyn AD, et al. Disorders of the oral cavity in Parkinson’s disease and parkinsonian syndromes. Parkinsons Dis. 2015;2015:379482.
   PubMedGoogle Scholar
• Cicciù M, Risitano G, Lo Giudice G, et al. Periodontal health and caries prevalence evaluation in patients affected by Parkinson’s disease. Parkinsons Dis. 2012;2012:541908.
   PubMedGoogle Scholar
• Touger-Decker R, van Loveren C. Sugars and dental caries. Am J Clin Nutr. 2003 Oct;78(4):881S–892S.
   PubMed Web of Science ®Google Scholar
• Willis AW, Schootman M, Evanoff BA, et al. Neurologist care in Parkinson disease: a utilization, outcomes, and survival study. Neurology. 2011 Aug30;77(9):851–857.
   PubMed Web of Science ®Google Scholar
• Cheng EM, Swarztrauber K, Siderowf AD, et al. Association of specialist involvement and quality of care for Parkinson’s disease. Mov Disord. 2007 Mar15;22(4):515–522.
   PubMed Web of Science ®Google Scholar
• Levine SR, Gorman M. “Telestroke”: the application of telemedicine for stroke. Stroke. 1999 Feb;30(2):464–469.
   PubMed Web of Science ®Google Scholar
• Fassbender K, Grotta JC, Walter S, et al. Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges. Lancet Neurol. 2017 Mar;16(3):227–237.
   PubMed Web of Science ®Google Scholar
• Zhao G, Huang H, Yang F. The progress of telestroke in China. Stroke Vasc Neurol. 2017 Jun 29;2(3):168–171.
   PubMedGoogle Scholar
• Bladin CF, Moloczij N, Ermel S, et al. Victorian stroke telemedicine project: implementation of a new model of translational stroke care for Australia. Intern Med J. 2015 Sep;45(9):951–956.
   PubMed Web of Science ®Google Scholar
• Sharma S, Padma MV, Bhardwaj A, et al. Telestroke in resource-poor developing country model. Neurol India. 2016 Sep–Oct;64(5):934–940.
   PubMed Web of Science ®Google Scholar
• Dorsey ER, Achey MA, Beck CA, et al. National randomized controlled trial of virtual house calls for people with Parkinson’s disease: interest and barriers. Telemed J E Health. 2016 Jul;22(7):590–598.
   PubMed Web of Science ®Google Scholar
• Beck CA, Beran DB, Biglan KM, et al. National randomized controlled trial of virtual house calls for Parkinson disease. Neurology. 2017 Sep 12;89(11):1152–1161.
   PubMed Web of Science ®Google Scholar
• Wilkinson JR, Spindler M, Wood SM, et al. High patient satisfaction with telehealth in Parkinson disease: a randomized controlled study. Neurol Clin Pract. 2016 Jun;6(3):241–251.
   PubMedGoogle Scholar
• Brown EM. The Ontario telemedicine network: a case report. Telemed J E Health. 2013 May;19(5):373–376.
   PubMed Web of Science ®Google Scholar
• Dorsey ER, Venkataraman V, Grana MJ, et al. Randomized controlled clinical trial of “virtual house calls” for Parkinson disease. JAMA Neurol. 2013 May;70(5):565–570.
   PubMed Web of Science ®Google Scholar
• Asch DA. The hidden economics of telemedicine. Ann Intern Med. 2015 Nov 17;163(10):801–802.
   PubMed Web of Science ®Google Scholar
• CMS. Next generation ACO model telehealth Waiver 2017. May 2017 [ cited]. https://innovation.cms.gov/Files/x/nextgenaco-telehealthwaiver.pdf
   Google Scholar
• Stingley S, Schultz H. Helmsley trust support for telehealth improves access to care in rural and frontier areas. Health Aff (Millwood). 2014 Feb;33(2):336–341.
   PubMed Web of Science ®Google Scholar
• Chaudhry HJ, Robin LA, Fish EM, et al. Improving access and mobility–the Interstate Medical Licensure Compact. N Engl J Med. 2015 Apr23;372(17):1581–1583.
   PubMed Web of Science ®Google Scholar
• Pearl R. Kaiser Permanente Northern California: current experiences with internet, mobile, and video technologies. Health Aff (Millwood). 2014 Feb;33(2):251–257.
   PubMed Web of Science ®Google Scholar
• Bloem BR. ParkinsonNet: a low-cost healthcare innovation with a systems’ approach from the Netherlands. Health Affairs.2017. In Press.
   Web of Science ®Google Scholar
• Bloem BR, Rompen L, Vries NM, et al. Revolutionising management of chronic disease: the ParkinsonNet approach. Health Aff (Millwood). 2017 Nov;36(11):1987–1996.
   PubMed Web of Science ®Google Scholar
• Parashos SA. Challenges of multidisciplinary care in Parkinson’s disease. Lancet Neurol. 2013 Oct;12(10):932–933.
   PubMed Web of Science ®Google Scholar